Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 4
Degenerative Neurological and Neuromuscular Disease
- View all (153)
- Volume 16, 2026 (9)
- Volume 15, 2025 (9)
- Volume 14, 2024 (11)
- Volume 13, 2023 (10)
- Volume 12, 2022 (11)
- Volume 11, 2021 (6)
- Volume 10, 2020 (4)
- Volume 9, 2019 (11)
- Volume 8, 2018 (8)
- Volume 7, 2017 (10)
- Volume 6, 2016 (11)
- Volume 5, 2015 (12)
- Volume 4, 2014 (13)
- Volume 3, 2013 (8)
- Volume 2, 2012 (14)
- Volume 1, 2011 (6)
Archive: Volume 4, 2014
Optical coherence tomography for retinal imaging in multiple sclerosis
Zimmermann H, Oberwahrenbrock T, Brandt AU, Paul F, Dörr J
Degenerative Neurological and Neuromuscular Disease 2014, 4:153-162
Published Date: 9 December 2014
Use of transcranial magnetic stimulation in the treatment of selected movement disorders
Brown KE, Neva JL, Ledwell NM, Boyd LA
Degenerative Neurological and Neuromuscular Disease 2014, 4:133-151
Published Date: 4 December 2014
Epigenetic mechanisms in Alzheimer’s disease [Corrigendum]
Balazs R
Degenerative Neurological and Neuromuscular Disease 2014, 4:131-132
Published Date: 15 September 2014
Intravenous immunoglobulin for the treatment of Alzheimer's disease: current evidence and considerations
Schindowski C, Zimmermann J, Schindowski K
Degenerative Neurological and Neuromuscular Disease 2014, 4:121-130
Published Date: 5 September 2014
Optimal management of multiple sclerosis during pregnancy: current perspectives
Borisow N, Paul F, Dörr J
Degenerative Neurological and Neuromuscular Disease 2014, 4:111-120
Published Date: 5 August 2014
Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review
Rojas JI, Patrucco L, Cristiano E
Degenerative Neurological and Neuromuscular Disease 2014, 4:103-109
Published Date: 20 June 2014
Epigenetic mechanisms in Alzheimer's disease
Balazs R
Degenerative Neurological and Neuromuscular Disease 2014, 4:85-102
Published Date: 24 May 2014
Identifying responders and nonresponders to interferon therapy in multiple sclerosis
Prosperini L, Capobianco M, Giannì C
Degenerative Neurological and Neuromuscular Disease 2014, 4:75-84
Published Date: 1 April 2014
Neurogenic overactive bladder in spinal cord injury and multiple sclerosis: role of onabotulinumtoxinA
Ethans KD, Casey AR, Bard RJ, Namaka MP
Degenerative Neurological and Neuromuscular Disease 2014, 4:65-73
Published Date: 18 March 2014
Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms
Levin MC, Douglas JN, Meyers L, Lee S, Shin Y, Gardner LA
Degenerative Neurological and Neuromuscular Disease 2014, 4:49-63
Published Date: 12 March 2014
Axonal transport and neurodegenerative disease: vesicle-motor complex formation and their regulation
Anderson EN, White II JA, Gunawardena S
Degenerative Neurological and Neuromuscular Disease 2014, 4:29-47
Published Date: 10 March 2014
Poststroke cognitive impairment and dementia: prevalence, diagnosis, and treatment
Melkas S, Jokinen H, Hietanen M, Erkinjuntti T
Degenerative Neurological and Neuromuscular Disease 2014, 4:21-27
Published Date: 5 February 2014
Critical analysis of the use of β-site amyloid precursor protein-cleaving enzyme 1 inhibitors in the treatment of Alzheimer's disease
Evin G, Barakat A
Degenerative Neurological and Neuromuscular Disease 2014, 4:1-19
Published Date: 22 January 2014